Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats. 2014

Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
Department of Toxicology (T.M., N.U., H.K., H.W., A.M., M.S., T.S.) and Institute of Medicinal Chemistry (K.H.), Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan; and Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan (K.Y.).

Previous studies have demonstrated that methylphenidate, MDMA (3,4-methylenedioxymethamphetamine), and other psychostimulants exert stimulant-like subjective effects in humans. Furthermore, MDMA and methylphenidate substitute for the discriminative stimulus effects of psychostimulants, such as amphetamine and cocaine, in animals, which suggests that MDMA and methylphenidate may produce similar discriminative stimulus effects in rats. However, there is no evidence regarding the similarities between the discriminative stimulus effects of MDMA and methylphenidate. To explore this issue, cross-substitution, substitution, and combination tests were conducted in rats that had been trained to discriminate between MDMA (2.5 mg/kg) or methylphenidate (5.0 mg/kg) and saline. In the cross-substitution tests, MDMA and methylphenidate did not cross-substitute for each other. In the substitution test, methamphetamine substituted for the discriminative stimulus effects of methylphenidate, but not for those of MDMA. Furthermore, ephedrine and bupropion, which activate dopaminergic and noradrenergic systems, substituted for the discriminative stimulus effects of methylphenidate. On the other hand, serotonin (5-HT) receptor agonists 5-HT1A and 5-HT2 fully substituted for the discriminative stimulus effects of MDMA. These results suggest that activation of the noradrenergic and dopaminergic systems is important for the discriminative stimulus effects of methylphenidate, whereas activation of the serotonergic system is crucial for the discriminative stimulus effects of MDMA. Even though MDMA, like psychostimulants, exerts stimulant-like effects, our findings clearly indicate that the discriminative stimulus effects of MDMA are distinctly different from those of other psychostimulants in rats.

UI MeSH Term Description Entries
D008297 Male Males
D008774 Methylphenidate A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE. Centedrin,Concerta,Daytrana,Equasym,Metadate,Methylin,Methylphenidate Hydrochloride,Phenidylate,Ritalin,Ritalin-SR,Ritaline,Tsentedrin,Hydrochloride, Methylphenidate,Ritalin SR
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D004193 Discrimination Learning Learning that is manifested in the ability to respond differentially to various stimuli. Discriminative Learning,Discrimination Learnings,Discriminative Learnings,Learning, Discrimination,Learning, Discriminative
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000097605 Sigma-1 Receptor A sigma receptor that regulates neuroinflammation, neurotransmitters, neurogenesis, ENDOPLASMIC RETICULUM stress and MITOCHONDRIA function. Receptor 1, Sigma
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D017480 Receptors, sigma A class of cell surface receptors recognized by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known (although they can react to certain endogenous steroids). Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues. Opioid Receptors, sigma,Receptors, Opioid, sigma,Receptors, sigma Opioid,sigma Receptors,sigma Receptor,Receptor, sigma,sigma Opioid Receptors

Related Publications

Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
October 1986, Drug and alcohol dependence,
Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
June 2009, The Journal of pharmacology and experimental therapeutics,
Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
July 2020, Journal of psychopharmacology (Oxford, England),
Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
June 2020, Behavioural pharmacology,
Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
June 2004, Drug and alcohol dependence,
Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
January 2024, The Journal of pharmacology and experimental therapeutics,
Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
April 1995, Behavioural pharmacology,
Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
October 1997, Pharmacology, biochemistry, and behavior,
Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
June 2017, Behavioural pharmacology,
Tomohisa Mori, and Naoki Uzawa, and Haruyo Kazawa, and Hirohiko Watanabe, and Ayano Mochizuki, and Masahiro Shibasaki, and Kazumi Yoshizawa, and Kimio Higashiyama, and Tsutomu Suzuki
November 2009, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!